Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors. (Record no. 16996058)

MARC details
000 -LEADER
fixed length control field 01515 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515064401.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200710s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0269-8811
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1177/0269881106075275
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lang, Undine E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20071004
245 00 - TITLE STATEMENT
Title Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of psychopharmacology (Oxford, England)
Date of publication, distribution, etc. Jul 2007
300 ## - PHYSICAL DESCRIPTION
Extent 553-5 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cognition
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclohexanols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Eye Diseases
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hallucinations
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Selective Serotonin Reuptake Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Syndrome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Venlafaxine Hydrochloride
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vision Disorders
General subdivision complications
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stogowski, Dariusz
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schulze, Doreen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Domula, Markus
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schmidt, Eckart
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gallinat, Jüergen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tugtekin, Sems Malte
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Felber, Werner
773 0# - HOST ITEM ENTRY
Title Journal of psychopharmacology (Oxford, England)
Related parts vol. 21
-- no. 5
-- p. 553-5
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1177/0269881106075275">https://doi.org/10.1177/0269881106075275</a>
Public note Available from publisher's website

No items available.